gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · SENSTechnologyIndustrial Instruments

Senseonics Holdings, Inc. Common Stock (SENS)

$8.86−1.34%
Close Nov 3, 2026 · split-adjusted
Nov 3, 2026$8.87▲ 28.92% in range
Nov 3, 2025Low $4.86 · High $10.34Nov 3, 2026
What changed · written from our data
As of Nov 3, 2026

Senseonics Holdings closed at $8.86 on Nov 3, down 1.34%, 14.3% below its 52-week closing high. Volume of 558.0K shares was 0.92× its 20-day average (close to normal).

Split-adjusted performance: -14.1% over one month, +77.2% over six months, +25.7% over one year.

In the quarter ended Jun 30, 2026, revenue was $14.48M, up 117.8% from a year earlier, with a net margin of -253.4%.

Short interest was 4.9M shares at the Oct 15 settlement, down 9.3% from the prior report (15.0% of float, 7.9 days to cover).

Market cap$468.5M52.9M shares
Revenue · quarter$14.5M+117.8% YoY
Diluted EPS$-0.63—
P/E · TTM—P/S 9.7×
Net margin-253.4%Gross 59.1%
Dividend yieldNone
52-week range4.86 – 10.34−14.3% from high
Volume558.0K0.92× 20-day avg
Volatility · 60d66.5%Annualised
Short % of float15.0%7.9 days to cover
Net cash$86.9MCash $142.7M
Next earnings—Not scheduled
Split-adjusted performance
1W +6.4%1M −14.1%3M +71.0%6M +77.2%YTD +60.5%1Y +25.7%3Y −8.1%5Y −87.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Industrial Instruments

Percentile among 15 companies (100 = best)

6-month momentum100
Revenue growth85
Net margin0
Value (low P/E)—
Size29

Industry medians: 6-month return +6.0%, revenue growth +11.7%, net margin 11.4%, P/E 36.2×.

Short interest

Details →
Shares short4.9M−9.3% vs prior
Days to cover7.9Settled Oct 15
% of float15.0%
Short vol. 10d48.4%of daily volume

Closest peers by size in Industrial Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
SENSSenseonics Holdings$8.86−1.34%+77.2%+117.8%−253.4%—$468.5M
MLABMesa Laboratories$125.48+2.88%+20.8%+1.0%4.7%146.3$702.2MCompare
HURCHurco Cos$22.04+0.69%+28.9%+3.2%4.7%—$142.7MCompare
STSensata Technologies Holding$41.64+0.99%−2.8%+7.7%11.4%16.5$6.06BCompare
SYPRSypris Solutions$1.34+3.88%−61.5%−3.5%−10.3%—$30.9MCompare
RALRalliant$71.31+7.54%+53.5%—10.1%—$7.89BCompare
CGNXCognex$58.11+3.01%−1.2%+16.9%25.0%55.9$9.78BCompare
CLIRClearSign Technologies Corporation Common Stock (DE)$2.43+4.74%−50.5%+321.1%−233.4%—$16.5MCompare
MKSIMKS$205.18+4.40%−28.7%+28.3%14.0%31.5$13.87BCompare

News about Senseonics Holdings

All news →
Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body ComponentGlobeNewswire Inc. · Oct 26, 2026▲ PositiveSenseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewswire Inc. · May 1, 2026▲ PositiveMiddle East and Africa Continuous Glucose Monitoring Market Forecast and Company Analysis Report 2026-2034 Featuring Dexcom, Medtronic, Senseonics, Abbott Diabetes Care, and GlySensGlobeNewswire Inc. · Apr 29, 2026▲ PositiveSenseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM SystemGlobeNewswire Inc. · Apr 24, 2026▲ PositiveFirst Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of WearGlobeNewswire Inc. · Mar 14, 2026▲ Positive

Quick answers

What does Senseonics Holdings do?
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management.
What is SENS's market cap?
$468.46M, based on the Nov 3 close of $8.86.
Does Senseonics Holdings pay a dividend?
No regular cash dividend has been paid in the last year.
How much of SENS is sold short?
4.9M shares, 15.0% of float, as of Oct 15, 2026.
What sector is SENS in?
Technology, in the Industrial Instruments industry.

About Senseonics Holdings

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.

HQ: Germantown, MD130 employeesListed Mar 18, 2016senseonics.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology